These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6991744

  • 1. [The fibrinolytic therapy in renal disease (author's transl)].
    Kaburagi T, Yokoyama S, Tanaka K, Haniu T, Suzuki T, Mithunami K, Takayama S, Oguma S, Hatori T, Kishimoto T, Tomimoto K.
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):59-79. PubMed ID: 6991744
    [No Abstract] [Full Text] [Related]

  • 2. [Studies on the fibrinolytic therapy in patients with various renal diseases. Clinical effects of urokinase (author's transl)].
    Takasaki H, Shibata M.
    Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1271-80. PubMed ID: 7035725
    [No Abstract] [Full Text] [Related]

  • 3. [Studies on thrombolytic therapy for venous thrombosis in the extremities--dynamics of plasmin inhibitor and FDP following administration of urokinase (author's transl)].
    Takeuchi S, Shiba T.
    Nihon Geka Hokan; 1979 May 01; 48(3):354-61. PubMed ID: 157109
    [No Abstract] [Full Text] [Related]

  • 4. [Studies on unexplained renal hematuria. 1. Clinical studies of peripheral blood examination and fibrinolytic enzyme systems in patients with various types of renal hematuria (author's transl)].
    Hayashi M.
    Nihon Hinyokika Gakkai Zasshi; 1981 Jan 01; 72(1):42-59. PubMed ID: 7024604
    [No Abstract] [Full Text] [Related]

  • 5. [Studies on blood coagulation and fibrinolytic activities in the cases of cerebral infarction treated with urokinase. 2nd Report -- espeically changes of coagulofibrinolytic system before and after UK infusion (author's transl)].
    Fujita S, Shou T, Yamamoto H, Ishikawa H, Itoga T.
    Rinsho Ketsueki; 1979 Jul 01; 20(7):745-53. PubMed ID: 501999
    [No Abstract] [Full Text] [Related]

  • 6. Urinary fibrin/fibrinogen derivatives.
    Hedner U.
    Thromb Diath Haemorrh; 1975 Dec 15; 34(3):693-708. PubMed ID: 54945
    [No Abstract] [Full Text] [Related]

  • 7. [Urokinase (in situ) in the case of acute ischemia of the lower limbs (author's transl)].
    Paillot J, Dumontier P, Raynov M, Ott B, Benichoux R.
    J Mal Vasc; 1981 Dec 15; 6(1):19-22. PubMed ID: 7026712
    [Abstract] [Full Text] [Related]

  • 8. [A study of fibrinolytic therapy in glomerulonephritis and nephrotic syndrome. III. Indication, time to start therapy and criteria of effect (author's transl)].
    Sato M, Nakazora H, Ohfuji T.
    Nihon Jinzo Gakkai Shi; 1977 Sep 15; 19(9):717-31. PubMed ID: 599731
    [No Abstract] [Full Text] [Related]

  • 9. [Thrombolytic treatment with urokinase (author's transl)].
    Tilsner V, Greul W.
    MMW Munch Med Wochenschr; 1975 May 16; 117(20):865-8. PubMed ID: 124400
    [Abstract] [Full Text] [Related]

  • 10. [Effect of urokinase therapy in patients with glomerulonephritis and nephrotic syndrome. Trial at multiple institutes in Japan].
    Tomura S, Takeuchi J, Tanaka K.
    Nihon Jinzo Gakkai Shi; 1984 Jan 16; 26(1):97-121. PubMed ID: 6376892
    [No Abstract] [Full Text] [Related]

  • 11. Fibrinogen-fibrin degradation products in renal disorders.
    Dube B, Srivastava PK, Padmanabhan R, Dube RK.
    Indian J Pathol Microbiol; 1979 Oct 16; 22(4):313-22. PubMed ID: 548482
    [No Abstract] [Full Text] [Related]

  • 12. [Biological changes during the local administration of small doses of urokinase].
    Michaud A, Aiach M, Fiessinger JN, Vayssairat M, Juillet Y.
    Nouv Presse Med; 1978 Oct 14; 7(35):3151. PubMed ID: 152910
    [No Abstract] [Full Text] [Related]

  • 13. Experimental and clinical studies on thrombolytic therapy with urokinase.
    Shiba T, Igarashi M, Takeuchi S, Awazu S, Asada T.
    Nihon Ketsueki Gakkai Zasshi; 1978 Aug 14; 41(4):771-81. PubMed ID: 82362
    [No Abstract] [Full Text] [Related]

  • 14. [Fibrinolytic treatment with urokinase in older phlebothrombosis (author's transl)].
    Trübestein G, Brecht T, Glänzer K, Koischwitz D, Etzel F.
    Med Klin; 1979 Sep 28; 74(39):1404-11. PubMed ID: 492059
    [Abstract] [Full Text] [Related]

  • 15. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. First report: Urinary fibrin/fibrinogen degradation products in primary glomerulonephritis (author's transl)].
    Miyamura S.
    Nihon Jinzo Gakkai Shi; 1978 Jan 28; 20(1):67-78. PubMed ID: 650992
    [No Abstract] [Full Text] [Related]

  • 16. [Use of urokinase during surgery: a new approach to the treatment of vascular obliterative disease (author's transl)].
    Fiessinger JN, Vayssairat M, Juillet Y, Janneau D, Aiach M, Cormier JM, Housset E.
    Ann Med Interne (Paris); 1979 Jan 28; 130(4):215-8. PubMed ID: 475207
    [Abstract] [Full Text] [Related]

  • 17. Changes in the plasma fibrinolytic system during urokinase therapy: comparison of tissue culture urokinase with urinary source urokinase in patients with pulmonary embolism.
    Marder VJ, Donahoe JF, Bell WR, Cranley JJ, Kwaan HC, Sashara AA, Barlow GH.
    J Lab Clin Med; 1978 Nov 28; 92(5):721-9. PubMed ID: 712206
    [No Abstract] [Full Text] [Related]

  • 18. [Disorders of the fibrinolytic activity of urine in certain kidney diseases].
    Karastanev I, Atanasov K.
    Urol Nefrol (Mosk); 1976 Nov 28; (3):19-21. PubMed ID: 973260
    [No Abstract] [Full Text] [Related]

  • 19. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S, Handa S, Abe S, Takahashi E, Kawai Y, Watanabe K, Yoshikawa T, Hori S, Ikeda Y.
    J Cardiol; 1993 Nov 28; 23(4):335-41. PubMed ID: 8064582
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.